| Website | novonordisk.com |
| @novonordisk | |
| Phone | +45 4444 8888 |
| Employees | |
| Founded | 1923 |
Novo Nordisk is a healthcare company and a world leader in diabetes care. In addition, Novo Nordisk has a leading position within areas such as haemostasis management, growth hormone therapy and hormone replacement therapy.
| Company | Date | Round | Size | Participants |
| Affimed Therapeutics | 4/10 | Series C | €20M | 3 |
| Osprey Pharmaceuticals USA | 5/08 | Series A | $11M | 6 |
| PIERIS Proteolab | 3/08 | Series B | $39.5M | 1 |
